|CHDD||Home | Site Map | Search | Directory | Admin Services||
||Center on Human Development and Disability|
|About CHDD | IDDRC | UCEDD|
Dr. Chamberlain researches the muscular dystrophies, primarily Duchenne muscular dystrophy (DMD), to develop a better understanding of the molecular basis of the pathophysiology of the diseases, and to develop gene and cell therapies to correct and treat them. DMD and also limb-girdle muscular dystrophy 2I is the most common form of muscular dystrophy, affecting one in 3,500 newborn males, and is caused by mutations in the dystrophin gene. Chamberlain and his associates are studying the structure and function of the dystrophin gene, as well as developing viral vectors to deliver this or other genes to muscle cells for possible gene therapy.
For more information on his research activities please see Jeffrey Chamberlain's page on the Chamberlain Lab website
University of Washington • Center on Human Development and Disability • Box 357920 • Seattle WA 98195-7920 USA • 206-543-7701 • firstname.lastname@example.org
Copyright © 1996—2017 Center on Human Development and Disability. Updated: September 16, 2021